Vheda Health Recognized as a Top 100 MBE(R)
Capital Region Minority Supplier Development Council (CRMSDC) honors Vheda Health as one of the best in the region.COLUMBIA, MD /...
News
KindlyMD(R) Announces New Partnership With Cigna Healthcare to Further Expand Patient Care Accessibility
KindlyMD now provides more than 90% statewide comprehensive insurance coverage SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024...
Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024
SEATTLE WA AND LUND, SWEDEN / ACCESSWIRE / October 29, 2024 / Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO) and Alligator Bioscience AB...
Sensio Air Wins Prestigious Red Dot Award for Design Excellence
Innovative Airborne Pathogen Monitoring Device Recognized for Outstanding Design and FunctionalitySUNNYVALE, CA / ACCESSWIRE / October 29, 2024 / Sensio...
Avinger to Announce Third Quarter 2024 Results on November 7, 2024
REDWOOD CITY, CA / ACCESSWIRE / October 29, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High-Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value
The global CBD pet care market, which includes products for animals like dogs, cats, and horses, was valued at approximately...
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today...
Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio
FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos...
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
TORONTO, ON / ACCESSWIRE / October 29, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical...
Top Atlanta Plastic Surgery Practice, Premier Image Cosmetic & Laser Surgery, Welcomes Jennifer Liechty
Expert nurse practitioner Jennifer Liechty brings advanced facial rejuvenation techniques to Premier Image Cosmetic & Laser SurgeryATLANTA, GA / ACCESSWIRE...
AMD Global Telemedicine and Carefluence Announce Strategic Partnership to Enhance Telehealth Interoperability
The collaboration delivers greater value to clients for seamless data exchange, enhanced continuity of care, and improved clinical outcomes.CHELMSFORD, MA...
How a 5-Year-Old is Helping Save Lives: New Book by Telestroke CEO & Son Teaches Kids to Spot Stroke Signs
EAST BRUNSWICK, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- On World Stroke Day, Dr. Rajiv Narula, founder and CEO of...
Nova Leap Health Corp. Announces Expansion in Nova Scotia With Execution of Definitive Agreement and Provides Update on Florida Acquisition
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Oct. 29, 2024...
Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results
Unaudited quarterly revenue increased 10% year-on-year and 20% quarter-on-quarter Higher-margin, recurring cartridge revenue expected to surpass reader revenue as primary...
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
PITTSBURGH, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company...
Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
FREEHOLD, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer...
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ALLO-316, an AlloCAR T™ Investigational Product for Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)
RMAT Designation Follows Positive Proof-of-Concept Data from the ALLO-316 TRAVERSE Trial in Adult Patients with Advanced or Metastatic CD70 Positive...
NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Newly analyzed biomarker data from the initial dose-escalation Phase 1 AD trial found that troculeucel reduces GFAP, NfL, p-tau181, GDF-15,...
Contract Win
DXS INTERNATIONAL PLC (AQSE: DXSP) ExpectCare First Commercial Contract The Board of DXS International plc (“the Company” or “DXSP”), the...
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
CHATHAM, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated...